Complejo Hospitalario Universitario de Santiago
14
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)
Role: collaborator
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
Role: collaborator
Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis
Role: collaborator
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
Role: collaborator
Antihypertensive and Cardioprotective Evaluation of a Functional Olive Oil
Role: collaborator
Epidemiological Study of the Microbiota in Critically Ill Children
Role: collaborator
Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA)
Role: collaborator
Trophic Nutrition in Patients Submitted to High Flow Oxygen Therapy and / or Non Invasive Mechanical Ventilation
Role: collaborator
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
Role: collaborator
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)
Role: collaborator
Glycoxidation, Arterial Biomechanics, and Target Organ Damage
Role: lead
Coronariography in OUt of hosPital Cardiac arrEst
Role: collaborator
Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS)
Role: collaborator
Two Opposite Strategies of Weaning From Mechanical Ventilation
Role: collaborator
All 14 trials loaded